ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
Quantum Biosystems, an Osaka, Japan-based developer of gene-sequencing technology, has released raw data to demonstrate the accuracy and error rate of its direct electrical detection approach. Its silicon-chip-based system uses subnanometer gaps and picoamp-level currents to detect the conductance of single-stranded DNA and RNA molecules. The system does not use proteins or other reagents, which the company expects will lower operating costs. The race for low-cost sequencing technologies has recently heated up with Illumina’s launch of its HiSeq X Ten system (C&EN, Jan. 20, page 24).
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X